Computer-navigated THA Surgery for Total Hip Replacement
Trial Summary
What is the purpose of this trial?
Replacing diseased hip joints with prosthetic implants in a procedure called total hip arthroplasty (THA) is associated with high rates of patient satisfaction, pain relief, and functional improvement when the implant is appropriately placed. Incorrect implant size or placement may lead to a breadth of negative outcomes, which could result in the need for implant revision. It is difficult to assess the precise orientation of patient hips on the operating table, with one study revealing that only 26% of acetabular cups placed without technological assistance are correctly positioned. Using computer navigation as a guide to achieve optimal implant alignment may improve successful placement rates. The additional incorporation of real-time modeling software may further help realize higher rates of successful implant placement. This study, therefore, aims to investigate a computer navigation system coupled with real-time modeling software to establish the benefit of such technology in the operating room, and further improve positive patient outcomes following THA. We hypothesize that including technological assistance in THAs will yield better patient outcomes compared to surgeries performed freehand.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Computer-navigated THA surgery for Total Hip Replacement?
Is computer-navigated total hip replacement surgery safe?
Computer-navigated total hip replacement surgery is generally considered safe, with most adverse events being uncommon and preventable or easily treated. However, like any major surgery, there are risks of complications such as heart issues or blood clots, especially in older or obese patients.36789
How is computer-navigated THA surgery different from standard hip replacement treatments?
Computer-navigated THA surgery uses advanced technology to guide the surgeon in placing hip components more accurately, which can reduce the risk of complications like dislocation. This approach is different from traditional methods that rely heavily on the surgeon's experience and skill without technological assistance.410111213
Research Team
Brent Lanting, MD
Principal Investigator
London Health Sciences Centre/Lawson
Eligibility Criteria
This trial is for adults over 40 needing a hip replacement due to osteoarthritis, with a BMI under 40. They must be able to consent and follow study procedures. It's not for those with prior surgeries on the affected hip or lower spine, limited motion in the other hip, or certain spinal conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Planning
Participants undergo pre-operative planning using computer navigation and real-time modeling software to optimize implant placement
Surgery
Participants undergo total hip arthroplasty with or without computer navigation assistance
Post-operative Follow-up
Participants are monitored for safety and effectiveness, including MRI and CT examinations to assess various outcomes
Treatment Details
Interventions
- Computer-navigated THA surgery
- Standard of care THA surgery
Standard of care THA surgery is already approved in European Union, United States, Canada, Japan for the following indications:
- Severe hip arthritis
- Hip fractures
- Degenerative joint disease
- Severe hip arthritis
- Hip fractures
- Degenerative joint disease
- Osteonecrosis
- Severe hip arthritis
- Hip fractures
- Degenerative joint disease
- Severe hip arthritis
- Hip fractures
- Degenerative joint disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Lead Sponsor
Lawson Health Research Institute
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
Smith & Nephew, Inc.
Industry Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley